The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic review.
PURPOSE: To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patients with metastatic solid tumors. DESIGN: A systematic literature search to identify randomized trials comparing chemotherapy with and without Bevacizumab in metastatic cancer. The primary end...
Main Authors: | Limor Amit, Irit Ben-Aharon, Liat Vidal, Leonard Leibovici, Salomon Stemmer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3551962?pdf=render |
Similar Items
-
Correction: The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
by: Limor Amit, et al.
Published: (2013-01-01) -
Correction: The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review.
by: Limor Amit, et al.
Published: (2013-01-01) -
Intravitreal Bevacizumab (Avastin) Injection for Neovascular Glaucoma
by: Shahin Yazdani, et al.
Published: (2008-12-01) -
Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma
by: Subrata Mandal, et al.
Published: (2011-01-01) -
Using intravitreal bevacizumab (Avastin®) – Indian Scenario
by: Atul Kumar, et al.
Published: (2017-01-01)